Over-expression of PDGFR-β promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Wang, Hang ^a   Yin, Yangguang ^a   Li, Wei ^a   Zhao, Xiaohui ^a   Yu, Yang ^a   Zhu, Jinkun ^a   Qin, Zhexue ^a   Wang, Qiang ^a   Wang, Kui ^a   Lu, Wei ^a   Liu, Jie ^a   Huang, Lan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 6,7 DIMETHYL 2 PHENYLQUINOXALINE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; ENZYME INHIBITOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL KINASE; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 4-KINASE; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-SIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84857080131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030503     Document Type: Article

References (48)

1. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
2. Behrendt D, Ganz P, (2002) Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90: 40L-48L.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
4. He T, Smith LA, Harrington S, Nath KA, Caplice NM, et al. (2004) Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 35: 2378-2384.
5. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, et al. (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrowderived endothelial progenitor cells. Circulation 105: 3017-3024.
6. George J, Herz I, Goldstein E, Abashidze S, Deutch V, et al. (2003) Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 23: e57-60.
7. Mills NL, Tura O, Padfield GJ, Millar C, Lang NN, et al. (2009) Dissociation of phenotypic and functional endothelial progenitor cells in patients undergoing percutaneous coronary intervention. Heart 95: 2003-2008.
8. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
9. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, et al. (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
10. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, et al. (2007) Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev 21: 1546-1558.
11. Ciarrocchi A, Jankovic V, Shaked Y, Nolan DJ, Mittal V, et al. (2007) Id1 restrains p21 expression to control endothelial progenitor cell formation. PLoS One 2: e1338.
12. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, et al. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
13. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, et al. (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219.
14. Heldin CH, Westermark B, (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
15. Fredriksson L, Li H, Eriksson U, (2004) The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15: 197-204.
16. Holmgren L, Glaser A, Pfeifer-Ohlsson S, Ohlsson R, (1991) Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development 113: 749-754.
17. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C, (1999) Role of PDGF-B and PDGFR-beta in recruitmen of vascular smooth muscle cells and pericytes during embryonic blood vessels formation in the mouse. Development 126: 3047-3055.
18. Heldin CH, Ostman A, Rönnstrand L, (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: F79-113.
19. Cantley LC, (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
20. Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, et al. (2001) HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108: 399-405.
21. Urbich C, Knau A, Fichtlscherer S, Walter DH, Brühl T, et al. (2005) FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB 19: 974-976.
22. Urbich C, Dimmeler S, (2005) Risk factors for coronary artery disease,circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 67: 1672-1676.
23. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, et al. (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343.
24. Bao H, Jacobs-Helber SM, Lawson AE, Penta K, Wickrema A, et al. (1999) Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93: 3757-3773.
25. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, et al. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541.
26. Zhao X, Huang L, Yin Y, Fang Y, Zhao J, et al. (2008) Estrogen induces endothelial progenitor cells proliferation and migration by estrogen receptors and PI3K-dependent pathways. Microvasc Res 75: 45-52.
27. Yin Y, Huang L, Zhao X, Fang Y, Yu S, et al. (2007) AMD3100 mobilizes endothelial progenitor cells in mice,but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro. J Cardiovasc Pharmacol 50: 61-67.
28. Zhou L, Takayama Y, Boucher P, Tallquist MD, Herz J, (2009) LRP1 regulates architecture of the vascular wall by controlling PDGFRbeta-dependent phosphatidylinositol 3-kinase activation. PLoS ONE 4: e6922.
29. Choi KH, Kim JE, Song NR, Son JE, Hwang MK, et al. (2010) Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovascular Res 85: 836-844.
30. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, et al. (1994) Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367: 474-476.
31. DeMali KA, Whiteford CC, Ulug ET, Kazlauskas A, (1997) Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cgamma or phosphatidylinositol 3 kinase. J Biol Chem 272: 9011-9018.
32. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
33. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, et al. (2002) Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109: 337-346.
34. Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM, et al. (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108: 2511-2516.
35. Siow RC, Churchman AT, (2007) Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in. Cardiovasc Res 75: 659-668.
36. Lindner V, Giachelli CM, Schwartz SM, Reidy MA, (1995) A subpopulation of smooth muscle cells in injured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res 76: 951-957.
37. Levitzki A, (2005) PDGF receptor kinase inhibitors for the treatment of restenosis. Cardiovasc Res 65: 581-586.
38. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, et al. (1991) Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253: 1129-1132.
39. Deguchi J, Namba T, Hamada H, Nakaoka T, Abe J, et al. (1999) Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther 6: 956-965.
40. Raica M, Cimpean AM, (2010) Platelet-derived growth factor (PDGF)/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy. Pharmaceuticals 3: 572-599.
41. Majumdar K, Radotra BD, Vasishta RK, Pathak A, (2009) Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas. Surg Neurol 72: 54-60.
42. Plate KH, Breier G, Farrell CL, Risau W, (1992) Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 67: 529-534.
43. Vrekoussis T, Stathopoulos EN, Kafousi M, Navrozoglou I, Zoras O, (2007) Expression of endothelial PDGF receptors alpha and beta in breast cancer: Up-regulation of endothelial PDGF receptor beta. Oncol Rep 17: 1115-1119.
44. Tallquist M, Kazlauskas A, (2004) PDGF signaling in cells and mice. CytokineGrowth Factor Rev 15: 205-213.
45. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
46. Huang PH, Chen YH, Tsai HY, Chen JS, Wu TC, et al. (2010) Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 30: 869-877.
47. Sufen G, Xianghong Y, Yongxia C, Qian P, (2011) bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells. Cell Biol Int 35: 545-551.
48. Wyler von Ballmoos M, Yang Z, Völzmann J, Baumgartner I, Kalka C, et al. (2010) Endothelial Progenitor Cells Induce a Phenotype Shift in Differentiated Endothelial Cells towards PDGF/PDGFRb Axis-Mediated Angiogenesis. PLoS ONE 5: e14107.